Privia Health Group (PRVA) Projected to Post Quarterly Earnings on Thursday

Privia Health Group (NASDAQ:PRVA - Get Free Report) will likely be posting its Q1 2025 quarterly earnings results before the market opens on Thursday, May 8th. Analysts expect Privia Health Group to post earnings of $0.05 per share and revenue of $450.65 million for the quarter.

Privia Health Group Stock Up 1.8 %

Shares of PRVA stock traded up $0.42 during mid-day trading on Friday, reaching $23.32. 369,530 shares of the stock traded hands, compared to its average volume of 771,494. The company has a market cap of $2.83 billion, a price-to-earnings ratio of 233.22, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88. The stock's fifty day simple moving average is $23.50 and its two-hundred day simple moving average is $22.07. Privia Health Group has a 1-year low of $15.92 and a 1-year high of $26.04.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on PRVA. Truist Financial boosted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research note on Thursday, April 10th. Barclays upped their price target on Privia Health Group from $21.00 to $23.00 and gave the company an "equal weight" rating in a research report on Thursday, April 10th. Piper Sandler lifted their price objective on Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, February 28th. Canaccord Genuity Group increased their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research report on Friday, February 28th. Finally, Needham & Company LLC restated a "buy" rating and issued a $30.00 price target on shares of Privia Health Group in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $27.38.

Insider Transactions at Privia Health Group

In other news, CFO David Mountcastle sold 5,630 shares of Privia Health Group stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at $4,021,148.88. This trade represents a 3.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Parth Mehrotra sold 15,100 shares of Privia Health Group stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $352,283.00. Following the transaction, the chief executive officer now owns 454,281 shares of the company's stock, valued at $10,598,375.73. This trade represents a 3.22 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,484 shares of company stock valued at $799,163 over the last ninety days. 10.70% of the stock is owned by company insiders.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.